M E Bertrand
Overview
Explore the profile of M E Bertrand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
252
Citations
1685
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Wit R, van Dis D, Bertrand M, Tiemessen D, Siddiqi S, Oosterwijk E, et al.
Acta Biomater
. 2022 Nov;
155:323-332.
PMID: 36423818
Development of ready-to-use biomaterials and scaffolds is vital for further advancement of scaffold-based tissue engineering in clinical practice. Scaffolds need to mimic 3D ultrastructure, have adequate mechanical strength, are biocompatible,...
2.
Bauters C, Van Belle E, Meurice T, Letourneau T, Lablanche J, Bertrand M
Trends Cardiovasc Med
. 2011 Jan;
7(3):90-4.
PMID: 21235870
Restenosis remains the major limitation of percutaneous transluminal coronary angioplasty. Restenosis after balloon angioplasty is due to vascular remodeling and neointimal hyperplasia. In spite of encouraging results in animal models,...
3.
Van Belle E, Susen S, Jude B, Bertrand M
J Thromb Haemost
. 2007 Aug;
5 Suppl 1:238-45.
PMID: 17635732
Within the last 6 years, it has been demonstrated that drug-eluting stents (DES) reduce significantly angiographic and clinical restenosis after percutaneous coronary interventions. These results are consistent across several clinical...
4.
Hogan R, Wang L, Bertrand M, Willmore L, Bucholz R, Nassif A, et al.
AJNR Am J Neuroradiol
. 2006 Nov;
27(10):2149-54.
PMID: 17110686
Background And Purpose: We objectively assessed surface structural changes of the hippocampus in mesial temporal sclerosis (MTS) and assessed the ability of large-deformation high-dimensional mapping (HDM-LD) to demonstrate hippocampal surface...
5.
Lenzen M, Boersma E, Bertrand M, Maier W, Moris C, Piscione F, et al.
Eur Heart J
. 2005 Apr;
26(12):1169-79.
PMID: 15802360
Aims: The purpose of the Euro Heart Survey Programme of the European Society of Cardiology is to evaluate to which extent clinical practice endorses existing guidelines as well as to...
6.
7.
Mehta S, Yusuf S, Peters R, Bertrand M, Lewis B, Natarajan M, et al.
Lancet
. 2001 Aug;
358(9281):527-33.
PMID: 11520521
Background: Despite the use of aspirin, there is still a risk of ischaemic events after percutaneous coronary intervention (PCI). We aimed to find out whether, in addition to aspirin, pretreatment...
8.
Meurice T, Bauters C, Hermant X, Codron V, VanBelle E, Mc Fadden E, et al.
Lancet
. 2001 May;
357(9265):1321-4.
PMID: 11343737
Background: The DD genotype for the angiotensin-I converting enzyme (ACE I) deletion allele (D) polymorphism is a possible genetic risk factor for restenosis after coronary stent implantation. We aimed to...
9.
Van Belle E, Ketelers R, Bauters C, Perie M, Abolmaali K, Richard F, et al.
Circulation
. 2001 Mar;
103(9):1218-24.
PMID: 11238264
Background: Several reports have demonstrated a high mortality rate in diabetic patients treated by standard coronary balloon angioplasty. No clear explanation has been provided for this finding. Methods And Results:...
10.
Bertrand M, Simoons M, Fox K, Wallentin L, Hamm C, McFadden E, et al.
Eur Heart J
. 2000 Aug;
21(17):1406-32.
PMID: 10952834
No abstract available.